Goldman Sachs Group Inc Abbott Laboratories Put Options Transaction History

Goldman Sachs Group Inc

$605 Billion
Q3 2024

Put Options

19 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 14, 2024	SELL	$100.07 - $118.13 $1.74 Million - $2.06 Million	-17,400 Reduced 45.55%	20,800 $2.37 Million
Q2 2024 Aug 13, 2024	SELL	$100.73 - $112.44 $7.93 Million - $8.85 Million	-78,700 Reduced 67.32%	38,200 $3.97 Million
Q1 2024 May 15, 2024	SELL	$109.52 - $120.96 $8.4 Million - $9.28 Million	-76,700 Reduced 39.62%	116,900 $13.3 Million
Q4 2023 Feb 13, 2024	BUY	$90.19 - $110.4 $3.11 Million - $3.81 Million	34,500 Added 21.68%	193,600 $21.3 Million
Q3 2023 May 14, 2024	SELL	$95.53 - $114.62 $3.3 Million - $3.95 Million	-34,500 Reduced 17.82%	159,100 $15.4 Million
Q3 2023 Nov 14, 2023	SELL	$95.53 - $114.62 $6.89 Million - $8.26 Million	-72,100 Reduced 31.19%	159,100 $15.4 Million
Q2 2023 May 14, 2024	BUY	$100.78 - $112.29 $262,028 - $291,954	2,600 Added 1.14%	231,200 $25.2 Million
Q2 2023 Aug 14, 2023	BUY	$100.78 - $112.29 $262,028 - $291,954	2,600 Added 1.14%	231,200 $25.2 Million
Q1 2023 May 14, 2024	SELL	$96.86 - $114.01 $5.63 Million - $6.62 Million	-58,100 Reduced 20.27%	228,600 $23.1 Million
Q1 2023 May 11, 2023	SELL	$96.86 - $114.01 $5.63 Million - $6.62 Million	-58,100 Reduced 20.27%	228,600 $23.1 Million
Q4 2022 May 14, 2024	BUY	$95.06 - $111.52 $12.4 Million - $14.6 Million	130,800 Added 83.9%	286,700 $31.5 Million
Q4 2022 Feb 13, 2023	BUY	$95.06 - $111.52 $12.4 Million - $14.6 Million	130,800 Added 83.9%	286,700 $31.5 Million
Q3 2022 May 14, 2024	BUY	$96.76 - $112.03 $358,012 - $414,511	3,700 Added 2.43%	155,900 $15.1 Million
Q3 2022 Nov 10, 2022	BUY	$96.76 - $112.03 $358,012 - $414,511	3,700 Added 2.43%	155,900 $15.1 Million
Q2 2022 May 14, 2024	SELL	$102.07 - $123.37 $4.23 Million - $5.11 Million	-41,400 Reduced 21.38%	152,200 $16.5 Million
Q2 2022 Aug 15, 2022	SELL	$102.07 - $123.37 $12.5 Million - $15.1 Million	-122,500 Reduced 44.59%	152,200 $16.5 Million
Q1 2022 May 16, 2022	SELL	$114.02 - $139.04 $12.3 Million - $14.9 Million	-107,500 Reduced 28.13%	274,700 $32.5 Million
Q4 2021 Feb 14, 2022	BUY	$115.53 - $141.46 $20.8 Million - $25.4 Million	179,700 Added 88.74%	382,200 $53.8 Million
Q3 2021 Nov 10, 2021	BUY	$116.66 - $129.06 $23.6 Million - $26.1 Million	202,500 New	202,500 $23.9 Million

Others Institutions Holding ABT

# of Institutions

3,184

Shares Held

1.3B

Call Options Held

8.74M

Put Options Held

8.08M

Vanguard Group Inc Valley Forge, PA

168M
Shares

$19.5 Billion
0.35% of portfolio
Black Rock Inc. New York, NY

131M
Shares

$15.2 Billion
0.31% of portfolio
State Street Corp Boston, MA

76.7M
Shares

$8.89 Billion
0.36% of portfolio
Capital International Investors Los Angeles, CA

65.7M
Shares

$7.62 Billion
1.49% of portfolio
Capital Research Global Investors Los Angeles, CA

53.3M
Shares

$6.18 Billion
1.31% of portfolio

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $203B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Goldman Sachs Group Inc with notifications on news.

Account